MONTREAL, March 27, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it has been recognized on two of The Globe and Mail’s Report on Business magazine’s 2026 national benchmarks:
MONTREAL, March 27, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (Knight or the Company) is pleased to announce it has been recognized on two of The Globe and Mails Report on Business… [+5124 chars]







